Trial
NCT02835794
A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
Teva Pharmaceutical Industries, Ltd.
Condition
Myelodysplastic Syndromes
Intervention
Omacetaxine
Why stopped
Lack of funding to support clinical trial
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-03